[Federal Register Volume 75, Number 207 (Wednesday, October 27, 2010)]
[Notices]
[Pages 66114-66115]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-27187]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Scientific Management Review Board.
    The NIH Reform Act of 2006 (Pub. L. 109-482) provides 
organizational authorities to HHS and NIH officials to: (1) Establish 
or abolish national research institutes; (2) reorganize the offices 
within the Office of the Director, NIH including adding, removing, or 
transferring the functions of such offices or establishing or 
terminating such offices; and (3) reorganize divisions, centers, or 
other administrative units within an NIH national research institute or 
national center including adding, removing, or transferring the 
functions of such units, or establishing or terminating such units. The 
purpose of the Scientific Management Review Board (also referred to as 
SMRB or Board) is to advise appropriate HHS and NIH officials on the 
use of these organizational authorities and identify the reasons 
underlying the recommendations.
    The meeting will be open to the public.

    Name of Committee: Scientific Management Review Board.
    Date: November 10, 2010.
    Time: 1 p.m. to 2 p.m.
    Agenda: Presentation and discussion will focus on the most 
recent charge to the SMRB, which entails (1) identifying the 
attributes, activities, and functional capabilities of an effective 
translational medicine program for advancing therapeutics; and (2) 
broadly assessing, from a high-level view, the NIH landscape for 
extant programs, networks, and centers for inclusion in this network 
and

[[Page 66115]]

recommending their optimal organization. Time will be allotted on 
the agenda for public comment. To sign up for public comment, please 
submit your name and affiliation to the contact person listed below 
by November 9, 2010. Sign up will be restricted to one sign up per 
e-mail. In the event that time does not allow for all those 
interested to present oral comments, anyone may file written 
comments using the contact person address below.
    Dial-In Information: The toll-free number to participate in this 
call is 1-800-779-1545. Indicate to the conference operator that 
your participant pass code is ``NIH''.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Suite 750, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Lyric Jorgenson, Office of Science Policy, 
Office of the Director, NIH, National Institutes of Health, 6705 
Rockledge Drive, Suite 750, Bethesda, MD 20892; [email protected], 
(301) 496-6837.
    This meeting is being published less than 15 days prior to the 
meeting due to scheduling conflicts of the Members.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    The draft agenda, meeting materials, dial-in information, and 
other information about the SMRB, will be available at http://smrb.od.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: October 21, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-27187 Filed 10-26-10; 8:45 am]
BILLING CODE 4140-01-P